Full-Time

Quality Engineer

Posted on 5/9/2026

Novanta

Novanta

1,001-5,000 employees

Provides core photonics for medical tech

Compensation Overview

$56.4k - $115k/yr

+ Performance-based incentive compensation + Long-term incentives

Apex, NC, USA

In Person

Category
QA & Testing (1)
Required Skills
Data Analysis
Requirements
  • Bachelor's degree in an engineering discipline (except software) from an accredited institution, preferably mechanical or electrical engineering
  • Minimum of 2 years’ experience in a quality role in a manufacturing environment or 4 years in another role in a manufacturing environment
  • Experience maintaining EU, UL, and CE Marking compliance
  • Experience driving continuous improvement using established problem-solving methodologies (DMAIC, 8D, A3)
  • Technical problem solving and decision-making skills on electro-mechanical systems
  • Proven ability to work independently with high organizational and project management skills
  • Strong computer and keyboard skills, with focus on data management, data analysis, and word processing
  • Demonstrated ability to learn and obtain an intermediate working knowledge level of technical products and operating processes, i.e. ATI products and their applications
  • Advanced verbal and written communications skills
Responsibilities
  • Responsible Engineer for creating processes to assure ATI’s compliance to customer, regulatory, and ISO requirements
  • Responsible Engineer for addressing customer and internal quality issues through sound problem solving techniques and corrective action
  • Recommend action for improvement based on quality risk assessment of products and processes
  • Collaborate with the Design Group to provide input for preventing potential quality risk
  • Create quality plans for new product introductions
  • Track and analyze incoming, in-process and final inspection data for trends in order to facilitate improvement action
  • Participate in and facilitate Lean Manufacturing initiatives such as Kaizen events and defect reduction efforts
  • Assess and recommend quality equipment to meet current and future needs
Desired Qualifications
  • ASQ Certified Quality Engineer is a plus
  • Experience working in an ISO 13485:2016 compliant Quality System is a plus

Novanta designs and supplies core technology platforms for precision photonics used in medical devices and advanced industrial equipment. Its products are components and subsystems—such as lasers, optics, sensors, and imaging hardware—that OEMs integrate into their own machines. Unlike companies that sell end-user devices, Novanta focuses on providing the underlying photonics technology that OEMs build into products, enabling reliable performance and scalable manufacturing. The company differentiates itself through deep specialization in photonics and by growing through acquisitions, aligning its portfolio toward medical technology and precision industrial markets. Its goal is steady, long‑term growth by delivering proven core technologies that help customers develop better medical devices and industrial solutions.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Bedford, Texas

Founded

1968

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 bookings surged 37% with 1.10 book-to-bill ratio signaling revenue acceleration.
  • Medical segment hit 53% of sales with double-digit consumables growth in 2026.
  • $1.5B acquisition capacity targets medical tech and bioprocessing for expansion.

What critics are saying

  • Allient erodes market share after beating Q4 estimates by 7.5% while Novanta misses.
  • 93x P/E ratio triggers 20-30% correction if Q2 growth disappoints in 3-6 months.
  • Tariffs and manufacturing transfers compress margins despite 100bps gain in 12 months.

What makes Novanta unique

  • Novanta supplies precision photonics, vision, and motion components to medical OEMs since 1968 origins.
  • Sole-source provider for AI data center GPU board precision drilling, capturing 15% revenue.
  • Showcased Denali drives and Aura encoders for surgical robotics at CMEF 2026.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Novanta who can refer or advise you

Benefits

Health Insurance

Performance Bonus

Company News

Yahoo Finance
Mar 26th, 2026
Novanta falls 17% after revenue miss in otherwise strong Q4 for electronic components sector

As Q4 earnings season concludes, the nine electronic components stocks tracked showed strong performance, with revenues beating analyst consensus estimates by 3%. Share prices rose 5.2% on average since results were announced. Novanta posted revenues of $258.3 million, up 8.5% year-on-year, but fell short of analyst expectations by 0.9%. The company delivered the weakest performance against estimates in the group, with significant EBITDA misses. Its stock has dropped 17.4% since reporting, currently trading at $117.59. Allient led the group, reporting revenues of $143.4 million, up 17.5% year-on-year and beating expectations by 7.5%. The company also exceeded EBITDA estimates. Its shares have risen 6.3% since reporting, trading at $66.01.

EU-Startups
Mar 18th, 2026
Barcelona's Health Lean Analytics raises over $2.4M to automate hospital data with AI

Health Lean Analytics, a Barcelona-based startup automating hospital data collection, has raised over €2.1 million in a financing round combining private capital and public funding. US-listed Novanta joined as a technology and strategic partner, securing board representation. The round included an oversubscribed €1.4 million seed funding from family offices Inderhabs, Namarel and Braincats, plus a participative loan from Spain's National Innovation Company. Founded in 2023, HLA develops AI-powered hospital operations platforms that passively capture real-time clinical and operational data, particularly in surgical suites. The startup's technology integrates with existing hospital systems, using large language models to transform data into actionable insights. The funding will support domestic consolidation and US market entry within 12 months, whilst strengthening R&D capabilities in data automation and AI.

Yahoo Finance
Mar 4th, 2026
Harvey Partners bets $36M on Novanta despite flat stock performance

Harvey Partners disclosed a new position in Novanta, acquiring 304,000 shares worth $36.17 million during the quarter ending 17 February 2026, according to an SEC filing. The stake now represents 3.21% of the fund's reportable assets under management. Novanta, which provides photonics, vision and precision motion components for medical and industrial applications, has seen its shares remain roughly flat over the past year at around $145, significantly underperforming the S&P 500's 16% gain. The company reported revenue of $980.6 million in 2025, up 3% year over year, but operating income fell to $94 million from $110.6 million, whilst net income dropped from $64.1 million to $53.8 million. CEO Matthijs Glastra said the company plans to improve margins and cash flow this year.

Yahoo Finance
Feb 26th, 2026
Novanta CEO sells $1.1M worth of shares under pre-arranged trading plan

Novanta CEO Matthijs Glastra sold 7,500 common shares worth approximately $1.09 million on 10 February 2026, according to an SEC Form 4 filing. Following the transaction, Glastra holds 57,367 shares directly and 54,382 shares indirectly through a trust, with direct holdings valued at $8.3 million. The sale was executed under a pre-established Rule 10b5-1 trading plan adopted in September 2025, indicating routine liquidity management rather than concerns about company performance. The transaction matches Glastra's largest trade size in his 10 sell-only transactions since February 2023. Novanta manufactures photonics, vision and precision motion components for medical and industrial sectors, reporting $960.31 million in trailing twelve-month revenue and employing 3,000 people.

Yahoo Finance
Feb 24th, 2026
Novanta posts record Q4 on 25% bookings surge, targets $1.5B medical tech M&A

Novanta Inc. reported record fourth-quarter revenue and a return to organic growth, driven by a 25% surge in bookings across all business units. The precision technology company benefited from AI-driven demand in robotics, serving as the sole-source supplier for precision drilling of high-density GPU boards. Medical technology now represents 53% of total sales, with double-digit growth in consumables. However, the company experienced margin pressure due to regional manufacturing transfers, creating a temporary 100 basis point headwind. For 2026, Novanta projects mid-single-digit organic growth and 100 basis points of gross margin expansion once manufacturing transfers complete by Q2. The company plans to deploy nearly $1.5 billion in acquisition capacity towards medical technologies and bioprocessing. Operating cash flow is forecast at $145 million to $185 million.